John Hoekman - Jul 20, 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role
Chief Scientific Officer
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Jul 20, 2021
Transactions value $
$0
Form type
4
Date filed
7/26/2021, 05:58 PM
Previous filing
Jun 7, 2021
Next filing
Dec 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +50K $0.00 50K Jul 20, 2021 Common Stock 50K $12.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 2.0833% of the total shares on August 22, 2021 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2025, subject to the reporting person's provision of service to the issuer on each vesting date.